CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 30th, 2023 • OmniAb, Inc. • Services-commercial physical & biological research • California
This Change in Control Severance Agreement (“Agreement”) is made effective as of November 1, 2022, by and between OmniAb, Inc., a Delaware corporation (the “Company”), and Matthew W. Foehr (“Employee”).
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. ASSIGNMENT OF LEASE, CONSENT...OmniAb, Inc. • March 30th, 2023 • Services-commercial physical & biological research • California
This Assignment of Lease, Consent to Assignment of Lease and First Amendment to Lease (this “Amendment”), dated for reference purposes only as of October 26, 2022, by EMERY STATION OFFICE II, LLC, a California limited liability company (“Landlord”), LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Assignor”), and OMNIAB, INC., a Delaware corporation (“Assignee” or “Tenant”).
